Patient age, gender, BMI, history of smoking, history of tuberculosis, comorbidities, history of whole lung lavage and GM-CSF inhalation therapy had no significant difference on whether patients had a decrease in oxygen saturation after COVID-19 infection. The gene discussed is CSF2; the disease is tuberculosis.